Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
RESEARCH TOOLSreports
Cyclacel Pharmaceuticals (CYCC) Ownership - Who Owns Cyclacel Pharmaceuticals?
611 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 26, 2023 | Spiro George Rombotis President & Ceo,director | Bought | $20092 |
| Dec 26, 2023 | Paul Mcbarron E. Vp, Fin, Cfo, Coo And Secretary,director | Bought | $6243 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 68,658 | Insider | 5.21% | 122,898 | |
| 65,863 | Insider | 5.00% | 117,895 | |
| 64,068 | Institution | 4.86% | 114,682 | |
| 55,452 | Insider | 4.21% | 99,259 | |
| 40,415 | Insider | 3.07% | 72,343 | |
| 39,415 | Insider | 2.99% | 70,553 | |
| 36,847 | Insider | 2.80% | 65,956 | |
| 33,378 | Insider | 2.53% | 59,747 | |
| 25,306 | Insider | 1.92% | 45,298 | |
| 18,196 | Insider | 1.38% | 32,571 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 64,068 | Institution | 4.86% | 114,682 | |
| 5,796 | Institution | 0.44% | 10,375 | |
| 5,564 | Institution | 0.42% | 9,960 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,796 | Institution | 0.44% | 11,998 |
FAQ
Who Owns Cyclacel Pharmaceuticals (CYCC)?
Currently, no data Available
What percentage of Cyclacel Pharmaceuticals (CYCC) stock is held by institutional investors?
Currently, no data Available
What percentage of Cyclacel Pharmaceuticals (CYCC) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cyclacel Pharmaceuticals (CYCC)?
Spiro George Rombotis owns the most shares of Cyclacel Pharmaceuticals (CYCC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.